Genetic analysis reveals a homozygous missense mutation in the Secretor alpha 1,2-fucosyltransferase gene in Lewis(a+b+) individuals, indicating the molecular basis of the weak Secretor allele.
A missense mutation (A385 to T), predicting an Ile129 to Phe substitution, in the human Secretor alpha 1,2-fucosyltransferase gene was present in double dose in Lewis(a+b+) individuals, but not in Lewis(a-b+) individuals. Co-segregation of the Lewis(a+b+) phenotype with homozygosity for the mutation was also verified. These results yield a potential molecular basis for the weak Secretor allele (Sew) accounting for the Lewis(a+b+) phenotype.
No takes yet. Share an insight, caveat, or question.
Yu et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: